ReportGem ReportGem

REAL-TIME GLOBAL RESEARCH

Takeaways from 2Q26 Earnings Call - Focus on mRNA Vaccine and AIDD

Published: 2026-08-20Institution: Morgan StanleyCompany / ticker: 1093.HKPages: 9Original language: English
1093.HK coverageMorgan Stanley research

Research evidence excerpt

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer

Related research and intelligence

Quick Take: CSPC 2Q26 a solid beat on sales and licensing; mRNA strategy under the spotlight2026-08-20 · BernsteinRisk Reward Update2026-08-20 · Morgan Stanley1H26 Sales In-line, Adj. NP Above; Next Catalyst PD-1/VEGF Update at ESMO2026-08-21 · Morgan StanleyInvestor Day Takeaways: A Multi-Utility Platform Trading at an Unwarranted Discount2026-08-21 · Morgan StanleyModel Update Post F1Q27 Results2026-08-21 · Morgan StanleySovereign AI, more fragmented but also larger AI ecosystem2026-08-21 · Morgan Stanley